Resulax: Uses, Dosage & Side Effects

What Is Resulax and What Is It Used For?

Resulax is a rectally administered osmotic laxative that contains sorbitol as its sole active ingredient. Sorbitol is a sugar alcohol that occurs naturally in many fruits and is widely used in pharmaceutical and food products. When introduced into the rectum as a hyperosmolar solution, sorbitol draws water from the surrounding tissues into the bowel lumen by osmosis. This influx of water serves two important purposes: it softens hardened stool, making it easier to pass, and it provides a lubricating effect on the rectal and colonic mucosa, reducing friction and discomfort during bowel evacuation.

The mechanism of action of Resulax is entirely local. Unlike oral laxatives that must pass through the gastrointestinal tract and may take hours or even days to produce a result, Resulax acts directly at the site where it is needed. This localized approach is one of the key advantages of the micro-enema format: because the sorbitol solution is delivered directly into the rectum, the onset of action is remarkably fast, typically between 5 and 15 minutes. There is minimal systemic absorption of sorbitol when administered rectally, which contributes to the product’s favorable safety profile and explains why it has no known systemic side effects.

Resulax is supplied as a ready-to-use, pre-filled disposable tube containing 10 ml of rectal solution. Each tube is designed for single use, which ensures hygiene and accurate dosing. The tube features a smooth, pre-lubricated tip designed for comfortable insertion. The product does not require any mixing, dilution, or preparation before use, making it convenient and straightforward for patients of all ages.

The primary indication for Resulax is the relief of occasional (acute) constipation. Constipation is one of the most common gastrointestinal complaints worldwide, affecting an estimated 10–20% of the adult population according to the World Gastroenterology Organisation (WGO). It is particularly prevalent in older adults, pregnant women, and individuals with reduced physical mobility. While dietary and lifestyle modifications (increased fiber intake, adequate hydration, and regular exercise) remain the first-line approach to managing constipation, pharmacological intervention is frequently necessary when these measures are insufficient or when rapid relief is needed.

Beyond the treatment of occasional constipation, Resulax has several important clinical applications. It is commonly used for bowel preparation before diagnostic examinations of the lower intestine, such as rectoscopy (proctoscopy) and sigmoidoscopy. Adequate bowel preparation is essential for obtaining clear visualization of the rectal and colonic mucosa during these procedures, and a micro-enema like Resulax provides a quick, gentle method of emptying the lower bowel without the discomfort and prolonged preparation time associated with full bowel lavage solutions. Resulax is also used to facilitate bowel evacuation before and after childbirth and before or after surgical procedures, situations in which straining during defecation should be minimized to protect healing tissues and reduce the risk of complications.

What Should You Know Before Using Resulax?

Contraindications

Resulax has a very limited list of contraindications, reflecting the safety profile of its active ingredient sorbitol. The only absolute contraindication is a known allergy (hypersensitivity) to sorbitol. Sorbitol allergy is extremely rare, but if you have previously experienced an allergic reaction to sorbitol in any form (including as a food additive or in other pharmaceutical products), you should not use Resulax. Signs of an allergic reaction may include skin rash, itching, swelling, or difficulty breathing.

While not specifically listed as a contraindication, Resulax should be used with caution in patients with inflammatory bowel disease (such as Crohn’s disease or ulcerative colitis), intestinal obstruction, or acute abdominal conditions. In these situations, rectal administration of any product may be inadvisable, and a healthcare provider should be consulted before use. Similarly, patients who have recently undergone rectal or colorectal surgery should seek medical advice before using a micro-enema.

Warnings and Precautions

Although Resulax is a well-tolerated product with no known side effects at recommended doses, there are several general precautions to be aware of when using any laxative product:

• Persistent constipation: If constipation persists for more than a few days despite using Resulax, or if it is accompanied by abdominal pain, bloating, nausea, vomiting, or rectal bleeding, you should consult a healthcare provider. Persistent constipation may be a symptom of an underlying medical condition that requires further investigation.
• Chronic use: Resulax is intended for the relief of occasional constipation. It should not be used as a long-term daily treatment for chronic constipation without medical supervision. Chronic constipation requires a comprehensive management approach that may include dietary modification, increased physical activity, behavioral therapy, and potentially other classes of laxative medications.
• Abdominal pain of unknown origin: Do not use Resulax if you have acute abdominal pain, nausea, or vomiting of unknown cause. These symptoms may indicate a condition such as intestinal obstruction, appendicitis, or other acute abdominal emergency that requires medical evaluation.
• Rectal conditions: While Resulax is designed for gentle rectal use, patients with hemorrhoids, anal fissures, or rectal prolapse should exercise care during insertion to avoid exacerbating these conditions. If you experience significant pain or bleeding during or after use, discontinue and consult a healthcare provider.

Pregnancy and Breastfeeding

Resulax is considered safe for use during pregnancy and breastfeeding when used at the recommended dose. Constipation is a particularly common complaint during pregnancy, affecting up to 40% of pregnant women according to published literature. The hormonal changes of pregnancy (particularly elevated progesterone levels), reduced physical activity, iron supplementation, and mechanical compression of the bowel by the growing uterus all contribute to decreased bowel motility and constipation.

Because Resulax acts locally in the rectum with minimal systemic absorption, it is not expected to pose any risk to the developing fetus. The sorbitol in Resulax does not cross the placenta in clinically significant amounts when administered rectally. Similarly, there are no expected effects on the breastfed infant, as the negligible systemic absorption means that sorbitol does not appear in breast milk at meaningful concentrations.

Nevertheless, as with all medications used during pregnancy and breastfeeding, it is advisable to consult your healthcare provider or pharmacist before use. This recommendation applies particularly to women with complicated pregnancies or those taking multiple medications.

Driving and Operating Machinery

Resulax has no known effect on the ability to drive or operate machinery. The sorbitol acts locally in the rectum and does not affect the central nervous system, cognitive function, or reaction time. You may drive and carry out normal activities after using Resulax. However, as with any situation in which you may need to use a toilet urgently within 5 to 15 minutes, plan your activities accordingly.

How Does Resulax Interact with Other Drugs?

One of the notable advantages of Resulax compared to many oral laxative medications is its excellent drug interaction profile. Because sorbitol is administered rectally and acts locally in the lower bowel, it does not pass through the upper gastrointestinal tract where most oral drugs are absorbed. This means it cannot interfere with the absorption of concomitant oral medications, a concern that arises with many oral laxatives and osmotic agents.

Furthermore, the minimal systemic absorption of rectally administered sorbitol means that it does not enter the bloodstream in significant quantities and therefore cannot interact with other drugs at the level of hepatic metabolism (cytochrome P450 enzymes), plasma protein binding, or renal excretion. There are no reports in the medical literature of clinically significant drug interactions between rectally administered sorbitol and any other medication.

However, there are some general considerations to keep in mind when using rectal products alongside other medications:

• Other rectal medications: If you are using other rectally administered medications (such as suppositories, rectal creams, or enemas), allow adequate time between administrations. Using Resulax immediately before or after another rectal medication may reduce the effectiveness of either product, as the bowel evacuation triggered by Resulax could flush out the other medication before it has been fully absorbed.
• Other laxatives: While there is no pharmacological interaction between Resulax and oral laxatives, concurrent use of multiple laxative products may increase the risk of diarrhea, abdominal cramping, and electrolyte imbalance. If you are already taking an oral laxative, discuss the addition of Resulax with your healthcare provider or pharmacist.
• Oral medications with narrow therapeutic windows: Severe diarrhea from overuse of any laxative product can potentially affect the absorption of critical oral medications such as oral contraceptives, anticoagulants, or antiepileptic drugs. At recommended doses, Resulax is unlikely to cause diarrhea, but caution is warranted if multiple laxatives are used simultaneously.

What Is the Correct Dosage of Resulax?

Adults

For adults and adolescents, the recommended dose is the contents of one tube (10 ml rectal solution containing 8.5 g sorbitol) administered into the rectum. The administration is most easily performed while lying on your side with your knees slightly bent. After twisting off the closure ring, hold the tube with the tip pointing upward and grip it high on the body. Insert the tip into the rectum at a slight upward angle, squeeze out the entire contents, and withdraw the tube while keeping it squeezed (to prevent drawing the solution back into the tube). The effect typically occurs within 5 to 15 minutes.

If a single tube does not produce a satisfactory result, do not administer a second tube without first consulting a healthcare provider. Repeated use should be discussed with a doctor, as persistent constipation may warrant further investigation and a different treatment approach.

Children

Resulax can be used in children of all ages, including infants. The dose is the same as for adults: the entire contents of one tube (10 ml). For children aged 3 years and older, the tube tip is inserted fully into the rectum, just as for adults.

For children under 3 years of age, a special precaution is taken: the closure ring that was twisted off the tube is threaded back onto the tube tip to act as a depth stopper. This limits the insertion depth to approximately half the length of the tip, reducing the risk of discomfort or injury to the smaller rectum of a young child. It is important to ensure that the ring sits firmly on the tip before insertion and to exercise care so that the ring does not dislodge during administration.

Elderly

No dose adjustment is required for elderly patients. The standard dose of one tube (10 ml) applies. Constipation is particularly common in older adults due to factors such as reduced physical activity, decreased dietary fiber intake, medication side effects (many commonly prescribed drugs cause constipation), and age-related changes in bowel motility. Resulax provides a gentle and rapid option for occasional constipation in this population. Its localized action and lack of systemic side effects make it particularly suitable for elderly patients who may be taking multiple medications and are at risk of drug interactions with oral laxatives.

Step-by-Step Administration Guide

Follow these steps for correct administration of Resulax:

1. Twist off the closure ring from the tube tip.
2. For children under 3 years: Thread the closure ring onto the tube tip as a stopper so that only half the tip will be inserted. Ensure the ring is firmly attached before proceeding.
3. Hold the tube with the tip pointing upward and grip it high on the body of the tube.
4. Lie on your side with knees slightly bent (this is the easiest position for administration).
5. Insert the tip into the rectum at a slight upward angle. Squeeze out the entire contents.
6. Withdraw the tube while keeping it squeezed to prevent the solution from being drawn back into the tube.
7. Remain lying down if possible and wait for the effect, which usually occurs within 5 to 15 minutes.

Overdose

If too much Resulax has been administered, or if a child has accidentally ingested the product orally, contact a healthcare provider, hospital, or poison control center for assessment and advice. Although sorbitol is a naturally occurring sugar alcohol with low toxicity, ingestion of large amounts may cause gastrointestinal symptoms such as abdominal discomfort, flatulence, and diarrhea. Rectal administration of more than one tube in a short period may cause watery diarrhea and mild abdominal cramping, which typically resolve without intervention once the excess sorbitol has been evacuated.

What Are the Side Effects of Resulax?

According to the approved product information for Resulax, there are no known side effects associated with the use of this product at the recommended dose. This exceptionally favorable safety profile is attributed to the local mechanism of action of rectally administered sorbitol: the active ingredient acts in the rectum and lower colon without significant systemic absorption, meaning it does not reach the bloodstream in quantities sufficient to cause adverse effects in other organ systems.

The absence of reported side effects is consistent with the pharmacological properties of sorbitol. As a naturally occurring sugar alcohol found in many fruits (apples, pears, peaches, apricots) and widely used as a sweetener and excipient in pharmaceutical products, sorbitol has an extensive safety track record spanning decades. When administered rectally in the dose and volume contained in a Resulax tube, the osmotic effect is gentle and self-limiting.

However, while no side effects are formally listed, it is important to recognize that individual responses to any medication can vary. Some patients may experience:

• Mild rectal discomfort: A brief sensation of fullness, mild cramping, or urgency after administration is expected and is part of the normal pharmacological response rather than a true side effect.
• Local irritation: In rare cases, particularly with frequent or repeated use, some individuals may notice mild irritation of the rectal mucosa.
• Abdominal cramping: Mild, transient abdominal cramping may occur as the bowel responds to the stimulation, particularly if the bowel was distended with hardened stool prior to use.

These experiences are generally mild, transient, and self-limiting. They reflect the normal physiological response to rectal stimulation and bowel evacuation rather than adverse drug reactions.

Reporting Suspected Side Effects

Although Resulax has no known side effects, it remains important to report any suspected adverse reactions after the product has been approved for marketing. Post-marketing surveillance allows the continuous monitoring of the benefit-risk balance of all medicines. If you experience any unexpected symptoms that you believe may be related to the use of Resulax, report them to your national medicines regulatory agency (such as the EMA in Europe, the FDA in the United States, or the MHRA in the United Kingdom). Healthcare professionals and patients alike are encouraged to participate in this important safety monitoring process.

How Should You Store Resulax?

Proper storage of Resulax ensures that the product remains safe and effective throughout its shelf life. The following storage guidelines should be observed:

• Keep out of sight and reach of children: As with all medications, store Resulax in a location that is inaccessible to children. Although sorbitol has low toxicity, accidental ingestion or misuse by unsupervised children should be prevented.
• Expiry date: Do not use Resulax after the expiry date (Exp:) printed on the outer carton and on each individual tube. The expiry date refers to the last day of the stated month. Using expired products may result in reduced effectiveness.
• Storage conditions: Resulax does not have any special storage temperature requirements. It should be stored at normal room temperature, protected from excessive heat and direct sunlight. Do not freeze the product.
• Single use: Each tube is intended for single use only. Once opened, the remaining contents of a partially used tube should be discarded. Do not attempt to reseal or reuse a tube.

Disposal

Medicines should not be disposed of via wastewater (drains or toilets) or with household waste. Return unused or expired Resulax tubes to your pharmacy for proper disposal. These measures help to protect the environment. Your pharmacist can advise you on the appropriate disposal procedure in your country.

What Does Resulax Contain?

Resulax has a remarkably simple formulation, containing only two ingredients:

• Active substance: Sorbitol 8.5 g – the osmotic agent responsible for the therapeutic effect.
• Inactive ingredient: Purified water – used as the solvent to create the rectal solution.

This minimalist formulation is noteworthy because it means Resulax is free from preservatives, fragrances, dyes, parabens, and other additives that might cause irritation or allergic reactions in sensitive individuals. The simplicity of the formulation contributes to its excellent tolerability profile.

Appearance and Pack Sizes

Each Resulax tube contains 10 ml of clear, colorless to slightly yellowish rectal solution. The tube is made of flexible plastic with a smooth applicator tip designed for comfortable rectal insertion. Resulax is available in the following pack sizes:

Not all pack sizes may be marketed in every country. The availability of specific pack sizes varies by market and distribution channel.

Manufacturer

Resulax is marketed by Viatris (formerly Mylan), a global pharmaceutical company. The product is manufactured by Sidefarma, located in Prior Velho, Portugal. The marketing authorization is held by Viatris in multiple countries across Europe and beyond.